Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

CJC-1295 Fat Loss Results Timeline: Dosing Protocols Comparison

CJC-1295 (DAC) Solo 1–2mg twice weekly 4–6 weeks Sustained baseline elevation (6–8 day half-life) Long-term recomposition, users prioritizing convenience over peak amplitude Most practical for sustained protocols; lower side effect risk than daily dosing pepti

This comparison does not assign a generated winner or score.

  • CJC-1295 (DAC) Solo
  • 1–2mg twice weekly
  • 4–6 weeks
  • Sustained baseline elevation (6–8 day half-life)
  • Long-term recomposition, users prioritizing convenience over peak amplitude
  • Most practical for sustained protocols; lower side effect risk than daily dosing peptides
  • CJC-1295 + Ipamorelin Stack
  • CJC 1mg + Ipamorelin 200–300mcg daily
  • 3–5 weeks
  • Pulsatile peaks overlaid on elevated baseline
  • Faster visible results, higher cost, requires daily compliance
  • Accelerates timeline but increases injection frequency and expense; best for 8–12 week focused cuts
  • CJC-1295 No DAC
  • 100–200mcg 2–3x daily
  • 3–4 weeks
  • Short-duration pulses (30-minute half-life)
  • Users seeking natural pulsatility mimicry
  • Logistically impractical for most; offers no meaningful advantage over DAC version for fat loss
  • CJC-1295 + Caloric Deficit
  • 1–2mg twice weekly + 300–500 calorie deficit
  • Sustained elevation + metabolic deficit synergy
  • Standard recomposition or cut
  • The actual determinant of results; peptide without deficit yields minimal fat loss regardless of dosing
More references

Related material